Human Anti-VEGFA Recombinant Antibody (clone FD006) (CAT#: HPAB-0114-WJ)

This product is a humanized IgG antibody targeting human vascular endothelial growth factor (VEGF). This antibody has a good biological activity and can inhibit cell proliferation of vascular endothelial cells, obviously inhibit tumor growth, and effectively inhibit the growth of corneal neovascularization, and can be used for preparing targeted medicines of specific targeting VEGF antigens or angiogenesis inhibiting medicines.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Published Data
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
ELISA

Figure 1 Antigen binding identification of FD006 to bind VEGF.

Figure 1 Antigen binding identification of FD006 to bind VEGF.

(A) The binding activity of FD006 by ELISA.

Wang, Q., Yang, J., Tang, K., Luo, L., Wang, L., Tian, L., ... & Lv, M. (2014). Pharmacological characteristics and efficacy of a novel anti-angiogenic antibody FD006 in corneal neovascularization. BMC biotechnology, 14(1), 17.

IHC

Figure 2 Hematoxylin and eosin (HE) staining observation of corneas.

Figure 2 Hematoxylin and eosin (HE) staining observation of corneas.

At day 7, corneal neovascularization of various sizes (black arrowhead) were present in the superficial central corneal stroma after alkali burn (×200) and neovascularization containing RBCs in the corneal stroma were indicated with black arrowheads. Cornea stroma exhibited edema and mononuclear inflammatory response. In this plane of section, the corneal epithelium is relatively normal. Bar = 100 μm.

Wang, Q., Yang, J., Tang, K., Luo, L., Wang, L., Tian, L., ... & Lv, M. (2014). Pharmacological characteristics and efficacy of a novel anti-angiogenic antibody FD006 in corneal neovascularization. BMC biotechnology, 14(1), 17.

WB

Figure 3 The protein expression of neovascularization-related signal molecules in the cornea.

Figure 3 The protein expression of neovascularization-related signal molecules in the cornea.

β-actin served as an internal standard. The protein expression of VEGF, MMP-9, VEGFR-1, VEGFR-2 and ICAM-1 in the cornea was significantly weaker in antibody- or dexamethasone- treated samples.

Wang, Q., Yang, J., Tang, K., Luo, L., Wang, L., Tian, L., ... & Lv, M. (2014). Pharmacological characteristics and efficacy of a novel anti-angiogenic antibody FD006 in corneal neovascularization. BMC biotechnology, 14(1), 17.


Specifications

  • Host Species
  • Human
  • Derivation
  • Humanized
  • Type
  • Humanized IgG
  • Specificity
  • Human VEGF
  • Species Reactivity
  • Human
  • Clone
  • FD006
  • Applications
  • ELISA, IHC, WB
  • Related Disease
  • Colorectal Cancer

Product Property

  • Purity
  • >95% as determined by SDS-PAGE and HPLC analysis
  • Concentration
  • Please refer to the vial label for the specific concentration.
  • Buffer
  • PBS
  • Preservative
  • No preservatives
  • Storage
  • Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Applications

  • Application Notes
  • The VEGF antibody has been reported in applications of Enzyme-linked Immunosorbent Assay, Immunohistochemistry, Western Blot.

Target

  • Alternative Names
  • Vascular endothelial growth factor; VEGF

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone FD006"

See other products for "VEGFA"

Humanized Antibody

Immunotoxin

CAT Product Name Application Type
AGTO-L043L anti-VEGFA immunotoxin Ng76 (scFv)-Luffin-β Cytotoxicity assay, Functional assay

Chicken IgY Antibody

CAT Product Name Application Type
BRD-0623MZ Chicken Anti-VEGF Polyclonal IgY WB Chicken antibody

Neutralizing Antibody

Blocking Antibody

CAT Product Name Application Type
NEUT-2259CQ Mouse Anti-VEGFA Recombinant Antibody (clone A.4.6.1) ELISA, IP, WB, Block, FC, IHC Mouse IgG1, κ
NEUT-2267CQ Mouse Anti-VEGFA Recombinant Antibody (clone A15136B) WB, Block Mouse IgG2b, κ

Rabbit Monoclonal Antibody

CAT Product Name Application Type
MOR-3835 Rabbit Anti-VEGFA Recombinant Antibody (clone DS3835AB) FC, ICC, IF, IHC-P, IP, WB Rabbit IgG
MOR-4758 Rabbit Anti-Vegfa Recombinant Antibody (clone TH272DS) WB Rabbit IgG

ADCC Enhanced Antibody

CAT Product Name Application Type
AFC-TAB-465CQ Afuco™ Anti-VEGFA ADCC Recombinant Antibody (Varisacumab), ADCC Enhanced ELISA, IHC, FC, IP, IF, FuncS ADCC enhanced antibody
AFC-TAB-011 Afuco™ Anti-VEGFA ADCC Recombinant Antibody (Bevacizumab), ADCC Enhanced FC, IP, ELISA, Neut, FuncS, IF ADCC enhanced antibody

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for HPAB-0114-WJ. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare